World

Vaccine Leader Signs Deal for 1 Billion Covid-19 Doses a Year

Swiss drugmaker to ramp up output of experimental vaccine
Companies aim to produce first batches in U.S. in July

Drugs & Vaccines That Might End the Coronavirus

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Eric Pfanner and James Paton

May 1, 2020 at 6:52 AM UTC

Updated on

May 1, 2020 at 11:16 AM UTC

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Moderna Inc., one of the leaders among U.S. companies developing experimental vaccines against the coronavirus, entered a pact with Lonza Group AG aimed at manufacturing 1 billion doses a year.